Tower Research Capital LLC (Trc) Recursion Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 101,005 shares of RXRX stock, worth $443,411. This represents 0.02% of its overall portfolio holdings.
Number of Shares
101,005
Previous 5,427
1761.16%
Holding current value
$443,411
Previous $36,000
1383.33%
% of portfolio
0.02%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding RXRX
# of Institutions
365Shares Held
286MCall Options Held
3.28MPut Options Held
3.16M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl34.8MShares$153 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.3MShares$142 Million0.0% of portfolio
-
Baillie Gifford & CO24.4MShares$107 Million0.12% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$76 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$64.4 Million0.27% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $792M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...